Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
222
NCT03206229
Study Comparing TPI-120 and Neulasta Administered Through Subcutaneous Route in Healthy Adult Subjects
Phase: Phase 1
Role: Lead Sponsor
Start: Feb 13, 2017
Completion: Jan 18, 2018
NCT03202927
Comparative Immunogenicity Study Comparing TPI-120 to Neulasta® in Healthy Adult Subjects
Start: Mar 25, 2017
Completion: Apr 12, 2018